The agencies said Tuesday that they are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the shot.
FDA, CDC call for pause in use of Johnson & Johnson vaccine after ‘extremely rare’ cases of blood clots
